Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 1, 1993
Newer aspects of the reversible inhibitor of MAO-A and serotonin reuptake, brofaromineP C WaldmeierExperientia|September 15, 1980
Serotoninergic modulation of mesolimbic and frontal cortical dopamine neuronsP C WaldmeierEuropean Journal of Pharmacology|December 20, 1979
Analysis of the activation of dopamine metabolism by a serotonin uptake inhibitorP C WaldmeierPolish Journal of Pharmacology and Pharmacy|March 1, 1984
Effects of chronic antidepressant treatment on pre- and post-synaptic dopaminergic mechanisms. A short review of the literature and some complementary experimentsP C WaldmeierPharmacopsychiatry|March 1, 1987
Is there a common denominator for the antimanic effect of lithium and anticonvulsants?P C WaldmeierNaunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1985
On the reversibility of reversible MAO inhibitorsP C WaldmeierNaunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1991
The GABAB antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesisP C WaldmeierNaunyn-Schmiedeberg'S Archives of Pharmacology|September 1, 1981
Stimulation of central serotonin turnover by beta-adrenoceptor agonistsP C WaldmeierJournal of Neural Transmission. Supplementum|January 1, 1987
Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain)P C WaldmeierThe Journal of Pharmacy and Pharmacology|January 1, 1985
Displacement of striatal 5-hydroxytryptamine by dopamine released from endogenous storesP C WaldmeierPageof 8